Since 1998, more than $7.9 million has been raised for the Stefanie Spielman Fund for Patient Assistance and the Stefanie Spielman Fund for Breast Cancer Research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

The Stefanie Spielman Fund for Patient Assistance assists breast cancer patients and families who are struggling to afford the costs associated with treatment. The fund has provided essential equipment and services, including circulation pumps for lymphedema, compression garments, wigs, nutrition supplements, gas cards, restaurant gift cards and assistance with transportation.

The Stefanie Spielman Fund for Breast Cancer Research is devoted to advancing research in breast cancer. Over the past few years, the fund has supported researchers and their efforts. Currently, the fund is focused on supporting the following areas:

  • The Stefanie Spielman Chair in Cancer Imaging, currently held by Michael Tweedle, PhD. His work focuses on targeted molecular pharmaceuticals for imaging and therapy of cancer.
  • Researchers in Ohio State’s School of Pharmacy and the Comprehensive Cancer Center are developing new drugs for breast cancer. The fund will support continued efforts to discover and test these new drugs in clinical trials.
  • An invaluable resource to support breast cancer research is a large collection of breast cancers characterized by all the relevant pathological features of the cancers and the treatments and outcomes of the patients with these breast cancers. The fund is supporting two such efforts, the Spielman Breast Cancer Tissue Archive Services and Spielman Breast Cancer Tumor Bank. The Tissue Archive Services, under the leadership of Charles Shapiro, MD, Director of Breast Cancer Medical Oncology at Ohio State, uses breast cancers already collected and stored in the Ohio State Pathology Department. The Tumor Bank collects breast cancers and blood samples from newly diagnosed patients. The Tissue Archive Services and the Tumor Bank allows for promising genes or proteins that first are discovered in the laboratory using cell lines or animal models to be quickly tested for their importance and relevance to human breast cancers that come from patients. Examples of ongoing research conducted using these resources include: the molecular factors associated with basaloid, or estrogen receptor negative, progesterone receptor negative and HER-2 negative (or “triple negative”) breast cancers, and the molecular factors associated with tamoxifen resistance.

Contact Us

The Stefanie Spielman Fund for Breast Cancer Research


Phone: 614-293-3752

Email

Support the Stefanie Spielman Fund

Stefanie Spielman Comprehensive Breast Center

Your donation of any amount is an investment in groundbreaking discoveries that will lead to our goal of a cancer-free world.

Donate Now